华海药业：氨酚氢可酮片获得美国FDA批准文号

格隆汇1月5日丨华海药业公告，制剂产品氨酚氢可酮片获得美国FDA批准文号，氨酚氢可酮片主要用于缓解中度到中重度疼痛。

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.